Brain imaging company EMVision Medical Devices has revealed what it called ‘exceptional’ results for its world-first emu scanner to identify stroke and stroke type. In total 307 participants were enrolled in the EMView trial and scanned with the EMVision emu brain scanner (pictured) at Liverpool Hospital, Royal Melbourne Hospital and the Princess Alexandra Hospital, including…
Brain imaging company EMVision Medical Devices has completed fabrication of the company’s First Responder (Gen 2) Proof of Concept device (pictured). The First Responder device represents an opportunity to fundamentally transform stroke and traumatic brain injury outcomes for patients by delivering neurodiagnostic technology directly to the point of care, including in ambulances, according to the…
Brain imaging company EMVision Medical Devices has completed its pilot commercial line and received a third and final milestone-related payment, worth $1.25 million, under the federal Modern Manufacturing Initiative. EMVision is developing bedside and portable machines for detecting stroke, with the former (known as emu) currently in clinical trials. In a statement to the ASX…
Medical imaging manufacturer EMVision Medical Devices has reported positive interim analysis from the latest clinical trials of its lightweight stroke imager. The multi-site clinical trials were focused on developing EMVision’s neurodiagnostic AI algorithms to aid in the diagnosis of suspected haemorrhagic or ischaemic stroke. EMVision is one of two Australian companies developing lightweight imaging devices…
Imaging company EMVision Medical Devices is preparing for a meeting with the US Food and Drug Administration as it edges closer to seeking approval to market its emu point of care scanner to detect stroke. The company has been developing a system that uses microwaves and AI in a machine small enough to fit in…
US technology company Keysight Technologies has taken a strategic stake worth $15.28 million in medical imaging company EMVision. In a statement on Thursday, EMVision said the investment represented a significant milestone, and would accelerate commercialisation of the portable brain scanner emu, its first product. Keysight will be issued 7,454,231 new ordinary shares at $2.05 per…
Medical imaging manufacturer EMVision Medical Devices is further developing its innovative portable brain scanner. The company’s first generation scanner, which uses microwave imaging techniques to detect strokes at the point of care, is undergoing clinical testing. Now the Brisbane company has assembled an advanced 28-antenna prototype of its 2nd generation ultra-light weight helmet scanner (pictured)…
Brain imaging technology company EMVision Medical Devices has announced promising clinical trial results from a patient study of its haemorrhagic stroke detection algorithm. The algorithm, dubbed ‘blood or not’, is a critical part of the microwave imaging system the company is developing under a grant from the Australian Stroke Alliance, to be fitted to point…
Brain imaging company EMVision Medical Devices has announced receipt of a $1.75 million payment under the Modern Manufacturing Initiative (MMI) grant. EMVision was awarded a grant worth $5 million in non-dilutive funding in May 2022 from the previous federal government’s MMI. The funding under the initiative’s Translation stream is to assist establishing commercial production of…
Brain imaging technology company EMVision Medical Devices has moved to its second phase of human testing of its innovative portable brain scanner. The company’s first generation scanner, which uses microwave imaging techniques to detect strokes at an early stage, previously successfully completed a stage 1 trial with 30 healthy volunteers. The scanner is aimed for…
